NYSE:IMV - IMV Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.16 +0.05 (+1.22 %)
(As of 03/19/2019 10:37 AM ET)
Previous Close$4.11
Today's Range$4.15 - $4.23
52-Week Range$4.00 - $7.21
Volume300 shs
Average Volume29,046 shs
Market Capitalization$210.47 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. The company was founded by Warwick Kimmins and Brian Lowe on March 28, 2000 and is headquartered in Halifax, Canada.

Receive IMV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealth Technology
CUSIPN/A
CIKN/A
WebN/A
Phone(902) 492-1819

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$210.47 million
Next Earnings Date3/22/2019 (Confirmed)
OptionableNot Optionable

IMV (NYSE:IMV) Frequently Asked Questions

What is IMV's stock symbol?

IMV trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMV."

When is IMV's next earnings date?

IMV is scheduled to release their next quarterly earnings announcement on Friday, March 22nd 2019. View Earnings Estimates for IMV.

What price target have analysts set for IMV?

2 brokers have issued 12 month price targets for IMV's shares. Their predictions range from $10.00 to $10.00. On average, they anticipate IMV's stock price to reach $10.00 in the next year. This suggests a possible upside of 140.4% from the stock's current price. View Analyst Price Targets for IMV.

What is the consensus analysts' recommendation for IMV?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMV in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for IMV.

Has IMV been receiving favorable news coverage?

News coverage about IMV stock has trended somewhat positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. IMV earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days.

Who are some of IMV's key competitors?

What other stocks do shareholders of IMV own?

Who are IMV's key executives?

IMV's management team includes the folowing people:
  • Frederic Ors, CEO, Director & Chief Business Officer
  • Pierre Labbé, Chief Financial Officer
  • Gabriela Nicola Rosu, Chief Medical Officer
  • Marianne Stanford, Vice President-Research
  • Joseph Sullivan, Senior Vice President-Business Development

Who are IMV's major shareholders?

IMV's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Ruffer LLP (13.63%), Hartford Financial Management Inc. (0.06%), Prentiss Smith & Co. Inc. (0.05%) and Ipswich Investment Management Co. Inc. (0.01%).

Which institutional investors are selling IMV stock?

IMV stock was sold by a variety of institutional investors in the last quarter, including Prentiss Smith & Co. Inc..

Which institutional investors are buying IMV stock?

IMV stock was purchased by a variety of institutional investors in the last quarter, including Ruffer LLP, Ipswich Investment Management Co. Inc. and Hartford Financial Management Inc..

How do I buy shares of IMV?

Shares of IMV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IMV's stock price today?

One share of IMV stock can currently be purchased for approximately $4.16.

How big of a company is IMV?

IMV has a market capitalization of $210.47 million.

How can I contact IMV?

The company can be reached via phone at (902) 492-1819.


MarketBeat Community Rating for IMV (NYSE IMV)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  81
MarketBeat's community ratings are surveys of what our community members think about IMV and other stocks. Vote "Outperform" if you believe IMV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Featured Article: Discount Rate

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel